<DOC>
	<DOC>NCT02901587</DOC>
	<brief_summary>The purpose of this study is to investigate the effect of Lu AF35700 on electrical activity in the heart as measured on an electrocardiogram (ECG) in patients with schizophrenia or schizoaffective disorder after 6 weeks of treatment</brief_summary>
	<brief_title>Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>The patient is able by her/himself to provide informed consent to participate in the study The patient has a primary diagnosis of schizophrenia or schizoaffective disorder (DSM5™ criteria) The patient has BMI ≤35 kg/m2 The patient has a Clinical Global Impression Severity of Illness (CGIS) score ≤4 (moderately ill) PANSS total score ≤ 80 and a score ≤4 (moderate) on the PANSS items, P7 (hostility) and G8 (uncooperativeness) The patient is willing to be hospitalized for up to 8 weeks The patient is generally healthy based on medical history, physical examination, vital signs, ECG, and laboratory tests. The patient agrees to protocoldefined use of effective contraception ´ The patient experienced acute exacerbation of psychosis requiring hospitalization within the last 3 months or required change in medication due to exacerbation of psychosis within the last 8 weeks The patient has met moderate or severe comorbid Substance Abuse Disorder DSM5™ criteria in the last 3 months The patient is at significant risk of harming her/himself or others in the opinion of the investigator or according to Columbia Suicide Severity Rating Scale (CSSRS) The patient has tested positive for human immunodeficiency virus (HIV), hepatitis B surface antigen (HBsAg), or hepatitis C virus antibody (antiHCV) Other protocol defined inclusion and exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>